FSMBX
Price
$18.17
Change
+$0.11 (+0.61%)
Updated
Jul 31 closing price
Net Assets
16.03M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

FSMBX vs VSCIX

FSMBX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
FSMBX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMBX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. FSMBX (16M). VSCIX pays higher dividends than FSMBX: VSCIX (1.23) vs FSMBX (0.54). FSMBX was incepted earlier than VSCIX: FSMBX (7 years) vs VSCIX (29 years). FSMBX (1.34) is less costly to investors than VSCIX (0.03). FSMBX is a more actively managed with annual turnover of: 35.00 vs. VSCIX (17.00). FSMBX (5000000) and VSCIX (5000000) have matching initial minimum investment requirements. VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. FSMBX (12.55). VSCIX return over 5 years is better than : 35.13 vs. FSMBX (23.35).
FSMBXVSCIXFSMBX / VSCIX
Total Expense Ratio0.900.033,000%
Annual Report Gross Expense Ratio1.340.034,467%
Fund Existence7 years29 years-
Gain YTD13.56314.59193%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets16M189B0%
Annual Yield % from dividends0.541.2344%
Returns for 1 year12.5522.5856%
Returns for 3 years21.5543.4450%
Returns for 5 years23.3535.1366%
Returns for 10 yearsN/A156.07-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C